StoneX Group’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$69.6K Buy
+15,066
New +$66.9K ﹤0.01% 1555

Other funds holding AQST

StoneX Group's AQST Position: Q3 2026 in Review

StoneX Group opened a new position in Aquestive Therapeutics (AQST) in Q3 2026: 15,066 shares worth $69.6K. The stake represents ﹤0.01% of the portfolio and ranks #1555 among its holdings.

190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

  • StoneX Group held 15,066 shares of Aquestive Therapeutics worth $69.6K as of Q3 2026.
  • Aquestive Therapeutics was a new StoneX Group position in Q3 2026.
  • Aquestive Therapeutics made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1555 holding.
  • 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.